Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonny Peter

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
The Lancet. Global Health|May 18, 2019
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluationAnil Pooran, Grant Theron, Lynn Zijenah, et al.
Allergy|June 24, 2025
Deciphering Immune Endotypes Within Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) SyndromeCamilla von Wachter, Milad Ameri, Tafadzwa Chimbetete, et al.
Plos Medicine|April 6, 2019
Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort studyAnkur Gupta-Wright, Elizabeth L Corbett, Douglas Wilson, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
A GWAS of ACE Inhibitor-Induced Angioedema in a South African PopulationJacquiline W Mugo, Cascia Day, Ananyo Choudhury, et al.
The Journal of Allergy and Clinical Immunology. Global|April 28, 2025
A GWAS of angiotensin-converting enzyme inhibitor-induced angioedema in a South African populationJacquiline W Mugo, Cascia Day, Ananyo Choudhury, et al.
Lancet (London, England)|November 2, 2013
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trialGrant Theron, Lynn Zijenah, Duncan Chanda, et al.
Vaccine|December 7, 2024
Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengtheningChenoa Sankar, Johanna C Meyer, Marione Schönfeldt, et al.
Frontiers in Medicine|June 15, 2026
Prospective longitudinal study of psychological sequelae, self-perception of body image, and quality of life in severe cutaneous adverse drug reactions: a case-control studyEddy M Zitha, Aneliswa Mpungose, Lovemore Mapahla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 4, 2025
Global Approach for Severe Cutaneous Adverse Reactions (GRASS) SurveyMoneerah AlGassim, Shanti Narayanasamy, Sara Vogrin MBiostat, et al.
BMC Infectious Diseases|July 2, 2015
Psychological distress and its relationship with non-adherence to TB treatment: a multicentre studyGrant Theron, Jonny Peter, Lynn Zijenah, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
The Lancet. Global Health|May 18, 2019
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluationAnil Pooran, Grant Theron, Lynn Zijenah, et al.
Allergy|June 24, 2025
Deciphering Immune Endotypes Within Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) SyndromeCamilla von Wachter, Milad Ameri, Tafadzwa Chimbetete, et al.
Plos Medicine|April 6, 2019
Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort studyAnkur Gupta-Wright, Elizabeth L Corbett, Douglas Wilson, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
A GWAS of ACE Inhibitor-Induced Angioedema in a South African PopulationJacquiline W Mugo, Cascia Day, Ananyo Choudhury, et al.
The Journal of Allergy and Clinical Immunology. Global|April 28, 2025
A GWAS of angiotensin-converting enzyme inhibitor-induced angioedema in a South African populationJacquiline W Mugo, Cascia Day, Ananyo Choudhury, et al.
Lancet (London, England)|November 2, 2013
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trialGrant Theron, Lynn Zijenah, Duncan Chanda, et al.
Vaccine|December 7, 2024
Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengtheningChenoa Sankar, Johanna C Meyer, Marione Schönfeldt, et al.
Frontiers in Medicine|June 15, 2026
Prospective longitudinal study of psychological sequelae, self-perception of body image, and quality of life in severe cutaneous adverse drug reactions: a case-control studyEddy M Zitha, Aneliswa Mpungose, Lovemore Mapahla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 4, 2025
Global Approach for Severe Cutaneous Adverse Reactions (GRASS) SurveyMoneerah AlGassim, Shanti Narayanasamy, Sara Vogrin MBiostat, et al.
BMC Infectious Diseases|July 2, 2015
Psychological distress and its relationship with non-adherence to TB treatment: a multicentre studyGrant Theron, Jonny Peter, Lynn Zijenah, et al.
Pageof 11